Literature DB >> 11860535

Clinicopathological study of the pattern and significance of cervical involvement in cases of endometrial adenocarcinoma.

L B Jordan1, A Al-Nafussi.   

Abstract

The pattern of cervical involvement in 107 endometrial adenocarcinomas was assessed. The cervix was involved in 29%, higher than noted in previous studies. In 40.6%, the lesion was confined to surface endocervical epithelium only; the remainder had cervical stromal involvement. In the majority only small areas within the circumference of the cervix were affected, indicating a need for adequate tissue sampling. In some cases, malignant epithelium was found as a "migrant" within the endocervical canal, entrapped within cervical mucus or applied to surface epithelium, supporting the concept that endometrial cancer spreads by surface contiguity or implantation rather than by deep tissue planes or via lymphatic channels. Our findings reinforce the view that high-grade lesions and histological subtypes such as uterine serous papillary carcinoma are associated with a later presentation, higher stage and poorer prognosis. We have identified atypical changes in endocervical epithelium that may be misinterpreted as cervical involvement, particularly in the form of atypical reserve cell hyperplasia with a micropapillary pattern that may reflect a reaction to the presence of tumor. It is our assertion that the presence of tumor "migrants", and not endocervical surface atypia, is an indicator of increased probability of cervical involvement by endometrial adenocarcinoma (P = 0.015).

Entities:  

Mesh:

Year:  2002        PMID: 11860535     DOI: 10.1046/j.1525-1438.2002.01076.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  4 in total

1.  Endometrial endometrioid adenocarcinoma of the uterine corpus involving the cervix: some cases probably represent independent primaries.

Authors:  Liuyan Jiang; Anais Malpica; Michael T Deavers; Ming Guo; Luisa Lina Villa; Gerard Nuovo; Maria J Merino; Elvio G Silva
Journal:  Int J Gynecol Pathol       Date:  2010-03       Impact factor: 2.762

2.  Gemcitabine for advanced endometrial cancer: a retrospective study of the Memorial sloan-Kettering Cancer Center experience.

Authors:  Rachel Nicole Grisham; Christina Adaniel; David M Hyman; Weining Ma; Alexia Iasonos; Carol Aghajanian; Jason Konner
Journal:  Int J Gynecol Cancer       Date:  2012-06       Impact factor: 3.437

3.  Comparison of FIGO 1988 and 2009 staging systems for endometrial carcinoma.

Authors:  Melis Gultekin; Ferah Yildiz; Gokhan Ozyigit; Havva Beyaz; Mutlu Hayran; Faruk Kose; Kunter Yuce; Ali Ayhan
Journal:  Med Oncol       Date:  2012-03-14       Impact factor: 3.064

4.  Blood Vessel Invasion in Endometrial Cancer Is One of the Mechanisms of Spread to the Cervix.

Authors:  Gunsu Kimyon Comert; Derman Basaran; Hayriye Ergin Akkoz; Burcin Celik; Selcan Sinaci; Osman Turkmen; Alper Karalok; Olcay Kandemir; Taner Turan
Journal:  Pathol Oncol Res       Date:  2018-10-25       Impact factor: 3.201

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.